Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment

Nicotine and Tobacco Research

Volumn 11, Issue 10, 2009, Pages 1142-1153

  Strong, David R ^a   Kahler, Christopher W ^a   Leventhal, Adam M ^a   Abrantes, Ana M ^a   Lloyd Richardson, Elizabeth ^a   Niaura, Raymond ^a   Brown, Richard A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ADULT; AFFECT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING HABIT; SURVIVAL; SUSTAINED DRUG RELEASE; THERAPY EFFECT; TOBACCO DEPENDENCE; TREATMENT RESPONSE;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COGNITIVE THERAPY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; SMOKING CESSATION;

EID: 70349538660     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntp111     Document Type: Article

References (58)

1. al'Absi, M., Hatsukami, D., Davis, G. L., & Wittmers, L. E. (2004). Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug and Alcohol Dependence, 73, 267-278.
2. Alloy, L. B., Hartlage, S., Metalsky, G. I., & Abramson, L. Y. (1987). The Depression Proneness Inventory: A brief, face-valid scale of vulnerability to depressive reactions in response to stress. Philadelphia, PA: Temple University.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
4. Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., & Fiore, M. C. (2004). Addiction motivation reformulated: An affective processing model of negative reinforcement. Psychological Review, 111, 33-51.
5. Blondal, T., Franzon, M., & Westin, A. (1997). A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. European Respiratory Journal, 10, 1585-1590.
6. Brandon, T. H. (1994). Negative affect as motivation to smoke. Current Directions in Psychological Science, 3, 33-37.
7. Brody, A. L., Mandelkern, M. A., Lee, G., Smith, E., Sadeghi, M., Saxena, S., et al.(2004). Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: A preliminary study. Psychiatry Research, 130, 269-281.
8. Brown, R. A., Burgess, E. S., Sales, S. D., Whiteley, J. A., Evans, D. M., & Miller, I. W.(1998). Reliability and validity of a smoking timeline follow-back interview. Psychology of Addictive Behaviors, 12 101-112.
9. Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., et al.(2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69, 471-480.
10. Brown, R. A., Niaura, R., Lloyd-Richardson, E. E., Strong, D. R., Kahler, C. W., Abrantes, A. M., et al.(2007). Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine & Tobacco Research, 9, 721-730.
11. Bruijnzeel, A. W., & Markou, A.(2003). Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse, 50, 20-28.
12. Burgess, E. S., Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Goldstein, M. G., et al.(2002). Patterns of change in depressive symptoms during smoking cessation: Who's at risk for relapse? Journal of Consulting and Clinical Psychology, 70, 356-361.
13. Catley, D., Harris, K. J., Okuyemi, K. S., Mayo, M. S., Pankey, E., & Ahluwalia, J. S.(2005). The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine & Tobacco Research, 7, 859-870.
14. Cinciripini, P. M., Wetter, D. W., Fouladi, R. T., Blalock, J. A., Carter, B. L., Cinciripini, L. G., et al.(2003). The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. Journal of Consulting and Clinical Psychology, 71, 292-301.
15. Collins, L. M., Graham, J. W., & Flaherty, B. P.(1998). An alternative framework for defining mediation. Multivariate Behavioral Research, 33, 295-312.
16. Cook, J. W., Spring, B., & McChargue, D.(2007). Influence of nicotine on positive affect in anhedonic smokers. Psychopharmacology (Berl), 192 87-95.
17. Cook, J. W., Spring, B., McChargue, D., & Hedeker, D.(2004). Hedonic capacity, cigarette craving, and diminished positive mood. Nicotine & Tobacco Research, 6, 39-47.
18. Davidson, R. J., Ekman, P., Saron, C. D., Senulis, J. A., & Friesen, W. V.(1990). Approach-withdrawal and cerebral asymmetry: Emotional expression and brain physiology. I. Journal of Personality and Social Psychology, 58, 330-341.
19. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1995). Structured Clinical Interview for DSM-IV axis I disorders. New York: New York State Psychiatric Institute.
20. Glick, S. D., Maisonneuve, I. M., & Kitchen, B. A.(2002). Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors. European Journal of Pharmacology, 448, 185-191.
21. Grambsch, P., & Therneau, T. (1994). Proportional hazards tests and diagnostics based on weighted residuals. Biometrika, 81, 515-526.
22. Haas, A. L., Muñoz, R. F., Humfleet, G. L., Reus, V. I., & Hall, S. M. (2004). Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. Journal of Consulting and Clinical Psychology, 72, 563-570.
23. Hall, S. M., Muñoz, R. F., Reus, V. I., Sees, K. L., Duncan, C., Humfleet, G. L., et al. (1996). Mood management and nicotine gum in smoking treatment: A therapeutic contact and placebo-controlled study. Journal of Consulting and Clinical Psychology, 64, 1003-1009.
24. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
25. Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., et al. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, 1195-1202.
26. Kahler, C. W., Brown, R. A., Ramsey, S. E., Niaura, R., Abrams, D. B., Goldstein, M. G., et al. (2002). Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. Journal of Abnormal Psychology, 111, 670-675.
27. Kenford, S. L., Smith, S. S., Wetter, D. W., Jorenby, D. E., Fiore, M. C., & Baker, T. B. (2002). Predicting relapse back to smoking: Contrasting affective and physical models of dependence. Journal of Consulting and Clinical Psychology, 70, 216-227.
28. Kinnunen, T., Doherty, K., Militello, F. S., & Garvey, A. J. (1996). Depression and smoking cessation: Characteristics of depressed smokers and effects of nicotine dependence. Journal of Consulting and Clinical Psychology, 64, 791-798.
29. Koob, G. F., & LeMoal, M. (2008). Addiction and the brain antireward system. Annual Review of Psychology, 59, 29-53.
30. Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., et al. (2002). Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug and Alcohol Dependence, 67, 219-223.
31. MacKinnon, D. P. (1994). Analysis of mediating variables in prevention and intervention research. National Institute on Drug Abuse Research Monographs, 139, 127-153.
32. MacKinnon, D. P., & Dwyer, J. H. (1993). Estimation of mediated effects in prevention studies. Evaluation Research, 17, 144-158.
33. MacKinnon, D. P., Lockwood, C. M., Hoffman, J. M., West, S. G., & Sheets, V. (2002). A comparison of methods to test mediation and other intervening variable effects. Psychological Methods, 7, 83-104.
34. McCarthy, D. E., Piasecki, T. M., Fiore, M. C., & Baker, T. B. (2006). Life before and after quitting smoking: An electronic diary ary study. Journal of Abnormal Psychology, 115, 454-466.
35. Paterson, N. E., Balfour, D. J., & Markou, A. (2007). Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. European Journal of Neuroscience, 25, 3099-3108.
36. Piasecki, T. M. (2006). Relapse to smoking. Clinical Psychology Review, 26, 196-215.
37. Piasecki, T. M., & Baker, T. B. (2000). Does smoking amortize negative affect? American Psychologist, 55, 1156-1157.
38. Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1998). Profiles in discouragement: Two studies of variability in the time course of smoking withdrawal symptoms. Journal of Abnormal Psychology, 107, 238-251.
39. Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003a). Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. Journal of Abnormal Psychology, 112, 3-13.
40. Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003b). Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. Journal of Abnormal Psychology, 112, 14-27.
41. Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003c). Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Experimental and Clinical Psychopharmacology, 11, 276-285.
42. Piasecki, T. M., Niaura, R., Shadel, W. G., Abrams, D., Goldstein, M., Fiore, M. C., et al. (2000). Smoking withdrawal dynamics in unaided quitters. Journal of Abnormal Psychology, 109, 74-86.
43. Piper, M. E., Federman, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., et al. (2007). Efficacy of bupropion alone and in combination with nicotine gum. Nicotine & Tobacco Research, 9, 947-954.
44. Piper, M. E., Federmen, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., et al. (2008). Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. Journal of Abnormal Psychology, 117, 94-105.
45. Shiffman, S., Balabanis, M. H., Gwaltney, C. J., Paty, J. A., Gnys, M., Kassel, J. D., et al. (2007). Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment. Drug and Alcohol Dependence, 91, 159-168.
46. Shiffman, S., Johnston, J. A., Khayrallah, M., Elash, C. A., Gwaltney, C. J., Paty, J. A., et al. (2000). The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berl), 148, 33-40.
47. Spring, B., Cook, J. W., Appelhans, B., Maloney, A., Richmond, M., Vaughn, J., et al. (2008). Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl), 196, 461-471.
48. Spring, B., Doran, N., Pagoto, S., McChargue, D., Cook, J. W., Bailey, K., et al. (2007). Fluoxetine, smoking, and history of major depression: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 75, 85-94.
49. Strong, D. R., Brown, R. A., Kahler, C. W., Lloyd-Richardson, E. E., & Niaura, R. (2004). Depression proneness in treatmentseeking smokers: A taxometric analysis. Personality and Individual Differences, 36, 1155-1170.
50. Swan, G. E., Jack, L. M., Curry, S., Chorost, M., Javitz, H., McAfee, T., et al. (2003). Bupropion sr and counseling for smoking cessation in actual practice: Predictors of outcome. Nicotine & Tobacco Research, 5, 911-921.
51. Tein, J. Y., & MacKinnon, D. P. (2003). Estimating mediated effects with survival data. In H., Yanai, A., Rikkyo, K., Shigemasu, Y., Kano and J., Meulman (eds.), New developments in psychometrics: Psychometric society proceedings (pp. 405-412). Tokyo: Springer-Verlag.
52. Watson, D., & Clark, L. A. (1997). Measurement and mismeasurement of mood: Recurrent and emergent issues. Journal of Personality Assessment, 68, 267-296.
53. Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54, 1063-1070.
54. Watson, D., & Tellegen, A. (1985). Toward a consensual structure of mood. Psychological Bulletin, 98, 219-235.
55. Wei, I. (1978). Application of an urn model to the design of sequential controlled clinical trials. Journal of the American Statistical Association, 73, 559-563.
56. Wileyto, E. P., Patterson, F., Niaura, R., Epstein, L., Brown, R., Audrain-McGovern, J., et al. (2004). Do small lapses predict relapse to smoking behavior under bupropion treatment? Nicotine & Tobacco Research, 6, 357-366.
57. Wileyto, E. P., Patterson, F., Niaura, R., Epstein, L. H., Brown, R. A., Audrain-McGovern, J., et al. (2005). Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine & Tobacco Research, 7, 257-268.
58. Zelman, D. C., Brandon, T. H., Jorenby, D. E., & Baker, T. B. (1992). Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. Journal of Consulting and Clinical Psychology, 60, 943-952.